Glancy Prongay Wolke & Rotter LLP reminds Phreesia Inc. shareholders of a July 13, 2026 deadline to move for lead plaintiff in a class action covering purchases of Phreesia common stock between May 8, 2025 and March 30, 2026. The suit follows a March 30, 2026 after-hours announcement in which Phreesia sharply lowered its fiscal 2027 revenue growth projections, citing worsening visibility and weaker pharmaceutical marketing commitments in its Network Solutions segment. On March 31, 2026, the stock fell $3.03, or 26.6%, to close at $8.38 per share. The complaint alleges that during the class period, defendants misled investors by projecting confidence in fiscal 2027 revenue growth while downplaying risks from slowing Network Solutions growth, when in fact the durability of pharmaceutical marketing commitments was uncertain and put the revenue target at risk.
Phreesia IncPhreesia lowered fiscal 2027 revenue guidance, triggering a 26.6% stock drop and a securities fraud lawsuit.